1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCoentro, João Q.-
dc.contributor.authorPugliese, Eugenia-
dc.contributor.authorHanley, Geoffrey-
dc.contributor.authorRaghunath, Michael-
dc.contributor.authorZeugolis, Dimitrios I.-
dc.date.accessioned2018-10-24T10:00:57Z-
dc.date.available2018-10-24T10:00:57Z-
dc.date.issued2018-
dc.identifier.issn0169-409Xde_CH
dc.identifier.issn1872-8294de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/12107-
dc.description.abstractSkin is the largest organ of the human body. Being the interface between the body and the outer environment, makes it susceptible to physical injury. To maintain life, nature has endowed skin with a fast healing response that invariably ends in the formation of scar at the wounded dermal area. In many cases, skin remodelling may be impaired, leading to local hypertrophic scars or keloids. One should also consider that the scarring process is part of the wound healing response, which always starts with inflammation. Thus, scarring can also be induced in the dermis, in the absence of an actual wound, during chronic inflammatory processes. Considering the significant portion of the population that is subject to abnormal scarring, this review critically discusses the state-of-the-art and upcoming therapies in skin scarring and fibrosis.de_CH
dc.language.isoende_CH
dc.publisherElsevierde_CH
dc.relation.ispartofAdvanced Drug Delivery Reviewsde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subject.ddc617: Chirurgiede_CH
dc.titleCurrent and upcoming therapies to modulate skin scarring and fibrosisde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.1016/j.addr.2018.08.009de_CH
zhaw.funding.euNode_CH
zhaw.originated.zhawYesde_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedMetabolic Tissue Engineeringde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.
Show simple item record
Coentro, J. Q., Pugliese, E., Hanley, G., Raghunath, M., & Zeugolis, D. I. (2018). Current and upcoming therapies to modulate skin scarring and fibrosis. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2018.08.009
Coentro, J.Q. et al. (2018) ‘Current and upcoming therapies to modulate skin scarring and fibrosis’, Advanced Drug Delivery Reviews [Preprint]. Available at: https://doi.org/10.1016/j.addr.2018.08.009.
J. Q. Coentro, E. Pugliese, G. Hanley, M. Raghunath, and D. I. Zeugolis, “Current and upcoming therapies to modulate skin scarring and fibrosis,” Advanced Drug Delivery Reviews, 2018, doi: 10.1016/j.addr.2018.08.009.
COENTRO, João Q., Eugenia PUGLIESE, Geoffrey HANLEY, Michael RAGHUNATH und Dimitrios I. ZEUGOLIS, 2018. Current and upcoming therapies to modulate skin scarring and fibrosis. Advanced Drug Delivery Reviews. 2018. DOI 10.1016/j.addr.2018.08.009
Coentro, João Q., Eugenia Pugliese, Geoffrey Hanley, Michael Raghunath, and Dimitrios I. Zeugolis. 2018. “Current and Upcoming Therapies to Modulate Skin Scarring and Fibrosis.” Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2018.08.009.
Coentro, João Q., et al. “Current and Upcoming Therapies to Modulate Skin Scarring and Fibrosis.” Advanced Drug Delivery Reviews, 2018, https://doi.org/10.1016/j.addr.2018.08.009.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.